Investing in tomorrow's medicine
Mérieux Equity Partners is a global investment platform specialized in the healthcare & nutrition sector, working alongside entrepreneurs and companies with ambitious growth plan, offering them privileged access to sector-expertise and industrial network.
News
Mérieux Equity Partners has entered the capital of Addmedica – as a reference shareholder – in order to accelerate the company’s growth in France and internationally
11/12/2019
Inscripta Raises $125M in Series D Financing
10/12/2019
New funding brings total amount raised to $259.5M and will be used to accelerate commercialization of revolutionary Digital Genome Engineering Platform.
Merieux Equity Partners co-invests alongside IK Investment Partners in Mabtech
26/11/2019
Mabtech's products are used by researchers and companies worldwide to study immune responses in cancer, allergy, infectious diseases and monitor vaccine trials.
Key figures
30
16
600
(€ million)
3
